Alnylam Pharmaceuticals, Inc. has grown revenue 53% a year over three years and 50% a year over five. Revenue growth, 3-year annual rate: +53% (Biotechnology median +21%). Revenue growth, 5-year rate: +50%, growth has picked up over the last three years. Years of annual history on file: 18, FY2008 to FY2025, as filed.

ALNYAlnylam Pharmaceuticals, Inc.

HealthcareUSD

$239.03

$216.4652 weeks$491.22

Is it growing?

Is ALNY growing?

Alnylam Pharmaceuticals, Inc. has grown revenue 53% a year over three years and 50% a year over five.

+53%

Revenue growth, 3-year annual rate · Biotechnology median +21% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +50%
Revenue growth, 5-year rate · +53% over three · growth has picked up over the last three years
Years of annual history on file: 18
Years of annual history on file · FY2008 to FY2025, as filed

Details›